Evolent HealthEVH +9.54%65 Days Payable is 13.58 as of Mar. 2026, which is 57% below its 10-year median of 31.28. GuruFocus rates EVH with a GF Score™ of 65/100 and a GF Value™ of $11.07 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Evolent Health ranks worse than 87.5% on this metric.
The historical rank and industry rank for Evolent Health's Days Payable or its related term are showing as below:
EVH'
s Days Payable Range Over the Past 10 Years
Min: 12.04 Med: 31.28 Max: 105.6
Current: 15.6
During the past 13 years, Evolent Health's highest Days Payable was 105.60. The lowest was 12.04. And the median was 31.28.
EVH's Days Payable is ranked worse than 87.5% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 58.08
vs EVH: 15.60
Evolent Health's Days Payable
declined
from Mar. 2025 (18.41) to Mar. 2026 (13.58).
It may suggest that Evolent Healthaccelerated paying its suppliers.
Evolent Health Days Payable Related Terms
Evolent Health Days Payable Historical Data
* Premium members only.
The historical data trend for Evolent Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Evolent Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolent Health Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Evolent Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Evolent Health's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolent Health (EVH) has a Days Payable of 13.58 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Evolent Health and its competitors. This is 57% below median its historical median of 31.28. Over the past decade, Evolent Health's Days Payable has ranged from 12.04 to 105.60. According to the industry distribution chart, Evolent Health ranks #532 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 87.5%.
Is Evolent Health's Days Payable too high?
Evolent Health's current Days Payable of 13.58 is 57% below median its 10-year median of 31.28. Over the past 10 years, this metric has ranged from a low of 12.04 to a high of 105.60. The Healthcare Providers & Services industry median Days Payable is 58.08. Evolent Health's value of 13.58 is 76.6% below this industry median. Based on the distribution chart, Evolent Health ranks #532 out of 608 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Evolent Health has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Days Payable compare to NRC and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Evolent Health ranks #532 out of 608 companies for Days Payable. This places Evolent Health in the lower half of its industry. The industry median Days Payable is 58.08. Evolent Health's value of 13.58 is 76.6% below this benchmark. Historically, Evolent Health's own Days Payable has ranged from 12.04 to 105.60 over the past decade. While the company's 10-year median is 31.28 vs. the industry median of 58.08, Evolent Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.08, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evolent Health's current Days Payable of 13.58 is 76.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Evolent Health and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evolent Health's current Days Payable is 13.58, which is 57% below median its own 10-year median of 31.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.07, compared to a current price of $5.51 — trading 50.2% below its estimated fair value. The current Days Payable is 13.58, which is 57% below median its 10-year median of 31.28 and 76.6% below the Healthcare Providers & Services industry median of 58.08. Evolent Health's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Evolent Health (EVH), the current Days Payable is 13.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evolent Health (EVH) Overvalued in 2026?
Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued.
The current stock price of $5.51 is trading 50.2% below its estimated GF Value™ of $11.07.
GuruFocus considers Evolent Health to be Possible Value Trap.
Key valuation signals for EVH:
Days Payable: 13.58 (57% below median its 10-year median of 31.28)
GF Value™: $11.07 vs. price of $5.51 (50.2% below fair value)
Industry Position: 76.6% below the Healthcare Providers & Services median (#532 of 608)
No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
65GF Score
Get the complete analysis for EVH
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EVH has been successfully added to your 
